<template>
  <div class="text-area">
    <p class="self"><b>Abdelhamid Benazzouz</b> is a Neurophysiologist Researcher employed by the Inserm Institute working in Bordeaux University. He is expert in the field of Neuroscience and especially in Parkinson’s disease. After completing a Master degree in Morocco, he went to Bordeaux to prepare his PhD diploma in the field of Neuroscience and Pharmacology. Dr. Benazzouz was the first to develop high frequency stimulation (HFS), named also deep brain stimulation (DBS), of the subthalamic nucleus (STN) as a therapeutical approach of Parkinson’s disease. Based on the spectacular improvement of motor symptoms obtained in Monkeys rendered parkinsonians by MPTP, he proposed the transfer of this neurosurgical approach to patients. He joined as a Neurophysiologist Research Fellow the Inserm unit of Professor Alim-Louis Benabid in Grenoble to participate in transfering this approach to parkinsonian patients, with a success that has never failed since. In parallel with his hospital activity as a Neurophysiologist performing the electrophysiological mapping during surgery, he was the head of a research team in the Inserm unit investigating the functional mechanisms of this approach in animal models. In 1998 he was appointed to Inserm position as a permanent position researcher. In 2001, he came back to Bordeaux as a Principal Investigator in the CNRS unit of Professor Bernard Bioulac. In 2005 he was promoted to Research Director position. Since 2011, he is the leader of the Team "Neurochemistry, Deep Brain Stimulation & Parkinson’s disease" in the Institute of Neurodegenerative diseases in Bordeaux University, in which he is investigating the respective role of monoamines in the pathophysiology of motor and non-motor symptoms of Parkinson’s disease. He has published more than 110 research papers in peer-reviewed journals and 25 chapters in scientific books as well as more than 70 research contributions at international conferences, international Neuroscience Schools and Universities. Internationally ranked among distinguished scholars, his publications are cited more than 17 thousand times and received 57 degrees on the global H-Index (Google Scholar).
      Awards and Prizes: He obtained the National Academy of Medicine award in 2003 and the Academy of Science award in 2007. In 2010, He obtained the distinction of Scientific Excellence delivered by Inserm.</p>
    <h3>Representative Publications</h3>
    <ul class="publics">
      <li>111) Charles K.A, Naudet F., Bouali-Benazzouz R. De Deurwaerdère P., Landry M., Fossat P*. and Benazzouz A*. Alteration of nociceptive integration in the spinal cord of a rat model of Parkinson’s disease. Mov. Disord. 2018 Jul;33(6):1010-1015. doi: 10.1002/mds.27377. (*PF & AB contributed equally)</li>
      <li>110) Tibar H., El Bayad K., Bouhouche A., Ait Ben Haddou E.H., Benomar A., Yahyaoui M., Benazzouz A.* and Regragui W.* Non-motor symptoms of Parkinson’s disease and their impact on quality of life in a cohort of Moroccan patients. Front. Neurol., 2018, April 04, 9:170. Doi: 10.3389/fneur.2018.00170. (*AB & WR contributed equally)</li>
      <li>109) Sabbar M., Delaville C., De Deurwaerdère P., Lakhdar-Ghazal N. and Benazzouz A. Lead-induced atypical Parkinsonism in Rats: Behavioral, Electrophysiological and Neurochemical Evidence for a role of Noradrenaline depletion. Front. Neurosci. 2018, March 19, 12:173. Doi: 10.3389/fnins.2018.00173.</li>
      <li>108) Faggiani E., Naudet F., Janssen M.L.F., Temel Y. and Benazzouz A. Serotonergic neurons mediate the anxiolytic effect of L-DOPA: neuronal correlates in the amygdala. Neurobiol. Dis. 2018, 110: 20–28, doi: 10.1016/j.nbd.2017.11.001.</li>
      <li>107) Lagière M., Bosc M., Whitestone S., Manem J, Elboukhari H., Benazzouz A., Di Giovanni G., De Deurwaerdère P. Does the Serotonin2C receptor segregate circuits of the basal ganglia responding to cingulate cortex stimulation? CNS Neurosci Ther. 2017 Nov 15. doi: 10.1111/cns.12777.</li>
      <li>106) Sabbar M., Dkhissi-Benyahya O., Benazzouz A. and Lakhdar-Ghazal N. Circadian clock gene expression and locomotor activity rhythm are altered after chronic exposure to lead. Front Behav Neurosci. 2017 Sep 22;11:178. doi: 10.3389/fnbeh.2017.00178.</li>
      <li>105) Miguelez C., Benazzouz A., Ugedo L. and De Deurwaerdere P. Impairment of the serotonergic transmission by the antiparkinsonian drug L-DOPA: mechanisms and clinical implications. Front Cell Neurosci. 2017 Sep 12;11:274. doi: 10.3389/fncel.2017.00274.</li>
      <li>104) Faggiani E, Benazzouz A. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: From history to the interaction with the monoaminergic systems. Prog Neurobiol. 2017, 151:139-156. doi: 10.1016/j.pneurobio.2016.07.003. Review</li>
      <li>103) Benazzouz A. Twenty-four years of deep brain stimulation of the subthalamic nucleus. Rev. Neurol. (Paris), 2017, 173(3):103-105. doi: 10.1016/j.neurol.2016.12.001. Editorial</li>
      <li>102) Janssen ML.F., Temel Y., Delaville C ., Zwartjes D.G.M., Heida T., De Deurwaerdère P., Visser-Vandewalle V. and Benazzouz A. Cortico-subthalamic inputs from the motor, limbic and associative areas in normal and dopamine-depleted rats are not fully segregated. Brain Struct Funct. 2017 Aug;222(6):2473-2485. doi: 10.1007/s00429-016-1351-5.</li>
      <li>101) Benazzouz A., Gross C., Bioulac B. Non-Human Primate: An Essential Building Brick in the Discovery of the Subthalamic Deep Brain Stimulation Therapy. Front Aging Neurosci. 2016 Jan 12;7:252. doi: 10.3389/fnagi.2015.00252. Commentary</li>
      <li>100) Bouabid S., Tinakoua A., Lakhdar-Ghazal N. and Benazzouz A.. Manganese Neurotoxicity: behavioral disorders associated with dysfunctions in the basal ganglia and neurochemical transmission. J. Neurochem., 2016, 136:677–691. doi: 10.1111/jnc.13442. Review</li>
      <li>99) Kölbl F., N’kaoua G., Naudet F., Berthier F., Faggiani E., Renaud S., Benazzouz A., Lewis N. A New Embedded Deep Brain Stimulator for Chronic Experiments in Freely Moving Rodents. IEEE Transactions on Biomedical Circuits and Systems. 2016, 10(1):72-84. doi: 10.1109/TBCAS.2014.2368788. Epub 2014 Dec 23.</li>
      <li>98) Bouabid S., Fifel K., Benazzouz A. and Lakhdar-Ghazal N. Consequences of manganese intoxication on the daily and circadian rest-activity rhythms in the rat. Neuroscience, 2016, 331:13-23.</li>
      <li>97) Miguelez C., Navailles S., Delaville C., Marquis L., Lagière M., Benazzouz A. Ugedo L. and De Deurwaerdère P. L-DOPA elicits non-vesicular releases of serotonin and dopamine in hemiparkinsonian rats in vivo. Eur Neuropsychopharmacol. 2016, 26(8):1297-309. doi: 10.1016/j.euroneuro.2016.05.004. Epub 2016 May 24.</li>
      <li>96) van Dijk KJ, Janssen MLF, Zwartjes DGM, Temel Y, Visser-Vandewalle V, Veltink PH, Benazzouz A and Heida T. Spatial Localization of Sources in the Rat Subthalamic Motor Region Using an Inverse Current Source Density Method. Front. Neural Circuits, 2016, 10:87. doi: 10.3389/fncir.2016.00087.</li>
      <li>95) Faggiani E, Delaville C, Benazzouz A. The combined depletion of monoamines alters the effectiveness of subthalamic deep brain stimulation. Neurobiol. Dis. 2015, 82:342-348. doi: 10.1016/j.nbd.2015.07.010.</li>
      <li>94) Mamad O., Delaville C., Benjelloun W. and Benazzouz A.  Dopaminergic control of the globus pallidus through activation of D2 receptors and its impact on the electrical activity of subthalamic nucleus and substantia nigra reticulata neurons. PlosOne 2015, 10(3):e0119152. doi: 10.1371/journal.pone.0119152. eCollection 2015.</li>
      <li>93) Tinakoua A, Bouabid S, Faggiani E, De Deurwaerdère P, Lakhdar-Ghazal N and Benazzouz A. The impact of combined administration of Paraquat and Maneb on motor and non-motor functions in the rat. Neuroscience, 2015, 311:118-129. doi: 10.1016/j.neuroscience.2015.10.021.</li>
      <li>92) Bouabid S., Delaville C., De Deurwaerdère, P., Lakhdar-Ghazal N. and Benazzouz A. Manganese-induced parkinsonian-like motor and non motor deficits associated with changes in basal ganglia neuronal activity in the rat. PLoS ONE, 2014, 9(6): e98952. doi:10.1371/journal.pone.0098952.</li>
      <li>91) Benazzouz A., Mamad O., Abedi P., Bouali-Benazzouz R., Chetrit J. Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson’s disease. Front. Aging Neurosci., 2014, May 13, 6:87. eCollection 2014, doi: 10.3389/fnagi.2014.00087. Review</li>
      <li>90) Caire F, Guehl D, Burbaud P, Benazzouz A, Cuny E. Intraoperative 3D imaging control during subthalamic Deep Brain Stimulation procedures using O-arm(®) technology: Experience in 15 patients. Neurochirurgie. 2014 Dec;60(6):276-82. doi: 10.1016/j.neuchi.2014.05.005.</li>
      <li>89) Chetrit J.*, Taupignon A.*, Froux L., Morin S., Bouali-Benazzouz R., Naudet F., Kadiri N., Gross CE., Bioulac B. and Benazzouz A. Inhibiting constitutive activity of subthalamic D5 receptors reverses motor impairment in a rat model of parkinsonism. J. Neurosci., 2013, 33:14840-14849. (*These authors contributed equally)</li>
      <li>88) Abedi P.M., Delaville C., De Deurwaerdère P., Benjelloun W. and Benazzouz A. Intrapallidal administration of 6-hydroxydopamine mimics in large part the electrophysiological and behavioral consequences of major dopamine depletion in the rat. Neuroscience, 2013, 236:289–297. DOI: 10.1016/j.neuroscience.2013.01.043.</li>
      <li>87) Zbrzeski A., Lewis N., Rummens F., Jung R., N'Kaoua G., Benazzouz A., Renaud S. Low-Gain, low-noise integrated neuronal amplifier for implantable artifact-reduction recording System. Journal of Low Power Electronics and Applications (JLPEA), 2013, 3 :279-299. DOI:10.3390/jlpea3030279.</li>
      <li>86) Kolbl F., Sabatier J., N'Kaoua, G., Naudet F., Faggiani E., Benazzouz A. Renaud S. and Lewis N. Characterization of a Non Linear Fractional Model of Electrode-Tissue Impedance for Neuronal Stimulation. IEEE Biomedical Circuits and Systems Conference (BIOCAS). 2013, 338-341.</li>
    </ul>
  </div>
</template>

<script>
export default {
  
}
</script>

<style lang="scss" scoped>
.text-area {
  width: 80%;
  h3 {
    font-size: 2em;
  }
  p {
    line-height: 30px;
  }
  .publics {
    li {
      margin: 10px 0;
    }
  }
}
</style>
